Novartis and Roxane enter settlement over cancer treatment

11-04-2017

Novartis and Roxane enter settlement over cancer treatment

Novartis and Roxane Laboratories have entered into a settlement agreement following a patent dispute between the parties over a cancer treatment.


Novartis, Roxane, settlement, patent, Gleevec, patent infringement, cancer treatment, ANDA

LSIPR